Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$571,453,829
-$156,327,461 QoQ
Shares Held
916,467
-2.7% QoQ
Ownership
0.890%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#20
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. REGN ranks #2 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $571,453,829 | 916,467 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $727,781,290 | 941,941 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $729,365,431 | 944,933 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $553,718,993 | 984,792 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $503,248,725 | 958,569 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $635,339,897 | 1,001,750 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $751,386,338 | 1,054,829 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $965,716,368 | 918,645 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $1,016,058,026 | 966,726 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $954,275,145 | 991,465 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $919,049,681 | 1,046,408 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $878,271,139 | 1,067,210 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $742,168,468 | 1,032,884 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $948,677,995 | 1,154,573 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $839,823,016 | 1,164,012 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $818,926,587 | 1,188,797 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $708,860,631 | 1,199,162 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $838,882,038 | 1,201,114 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $759,924,432 | 1,203,326 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $726,237,179 | 1,200,035 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $648,745,883 | 1,161,503 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $556,929,306 | 1,177,092 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $600,493,649 | 1,242,975 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $720,270,043 | 1,286,702 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $764,077,892 | 1,225,171 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $469,268,660 | 961,045 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||